BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19075729)

  • 1. Neuroactive steroids as endogenous modulators of anxiety.
    Eser D; Baghai TC; Schüle C; Nothdurfter C; Rupprecht R
    Curr Pharm Des; 2008; 14(33):3525-33. PubMed ID: 19075729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroactive steroids and affective disorders.
    Eser D; Schüle C; Baghai TC; Romeo E; Uzunov DP; Rupprecht R
    Pharmacol Biochem Behav; 2006 Aug; 84(4):656-66. PubMed ID: 16831459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders.
    Eser D; Schüle C; Romeo E; Baghai TC; di Michele F; Pasini A; Zwanzger P; Padberg F; Rupprecht R
    Psychopharmacology (Berl); 2006 Jun; 186(3):373-87. PubMed ID: 16247651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; di Michele F; Schüle C; Pasini A; Zwanzger P; Padberg F; Rupprecht R
    Neuroscience; 2006; 138(3):1041-8. PubMed ID: 16310959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    Schüle C; Eser D; Baghai TC; Nothdurfter C; Kessler JS; Rupprecht R
    Neuroscience; 2011 Sep; 191():55-77. PubMed ID: 21439354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.
    Rupprecht R
    Psychoneuroendocrinology; 2003 Feb; 28(2):139-68. PubMed ID: 12510009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; Schüle C; Zwanzger P; Rupprecht R
    Expert Rev Endocrinol Metab; 2006 Jul; 1(4):517-526. PubMed ID: 30290461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.
    Ströhle A; Romeo E; di Michele F; Pasini A; Hermann B; Gajewsky G; Holsboer F; Rupprecht R
    Arch Gen Psychiatry; 2003 Feb; 60(2):161-8. PubMed ID: 12578433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.
    Ströhle A; Romeo E; di Michele F; Pasini A; Yassouridis A; Holsboer F; Rupprecht R
    Am J Psychiatry; 2002 Jan; 159(1):145-7. PubMed ID: 11772707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Neuroactive Steroids in Pain, Depression and Anxiety.
    Mifflin K; Benson C; Kerr B; Aricioglu F; Cetin M; Dursun S; Baker G
    Mod Trends Pharmacopsychiatry; 2015; 30():94-102. PubMed ID: 26436548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action.
    Uzunova V; Sampson L; Uzunov DP
    Psychopharmacology (Berl); 2006 Jun; 186(3):351-61. PubMed ID: 16249906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of endogenous neuroactive steroids.
    Reddy DS
    Crit Rev Neurobiol; 2003; 15(3-4):197-234. PubMed ID: 15248811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology.
    Rupprecht R; di Michele F; Hermann B; Ströhle A; Lancel M; Romeo E; Holsboer F
    Brain Res Brain Res Rev; 2001 Nov; 37(1-3):59-67. PubMed ID: 11744074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroactive steroids in neuropsychopharmacology.
    Rupprecht R; Holsboer F
    Int Rev Neurobiol; 2001; 46():461-77. PubMed ID: 11599310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women.
    Amin Z; Mason GF; Cavus I; Krystal JH; Rothman DL; Epperson CN
    Pharmacol Biochem Behav; 2006 Aug; 84(4):635-43. PubMed ID: 16860856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals.
    Brambilla F; Perini G; Serra M; Pisu MG; Zanone S; Toffanin T; Milleri S; Garcia CS; Biggio G
    Psychoneuroendocrinology; 2013 Oct; 38(10):2234-42. PubMed ID: 23702252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of allopregnanolone in depression and anxiety.
    Schüle C; Nothdurfter C; Rupprecht R
    Prog Neurobiol; 2014 Feb; 113():79-87. PubMed ID: 24215796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.